Pfizer and BioNTech
- May- 2022 -4 MayDH Latest News
As pandemic curbs ease, Pfizer maintains its COVID sales projection
After a series of increases to the sales estimate for its COVID-19 vaccination last year, Pfizer maintained sales forecasts for…
Read More » - Jan- 2022 -8 JanuaryUS
Pfizer vaccine provides protection for children from rare Covid-19 complications, says CDC
A paper released on Friday by the US Centers for Disease Control and Prevention revealed that taking two doses of…
Read More » - Dec- 2021 -25 DecemberDH Latest News
AstraZeneca vaccine booster effective against Omicron, Oxford study finds
A three-dose course of AstraZeneca’s COVID-19 vaccination is effective against the fast spreading Omicron coronavirus type, data from an…
Read More » - 19 DecemberUK
Vaccine doesn’t provide enough protection for young children: Pfizer
After a two-dose regimen failed to induce an adequate immunological response in children of ages 2, 3 and 4, Pfizer…
Read More » - 18 DecemberDH Latest News
Pfizer tests additional Covid-19 vaccine shots for kids under 5 in setback
Pfizer announced on Friday that it was altering its plans and testing three doses of its COVID-19 vaccine in babies…
Read More » - 17 DecemberDH NEWS
Pfizer seeks a full FDA approval of COVID-19 vaccination in adolescents
Pfizer and its German partner BioNTech SE announced on Thursday that they have submitted files for a full approval of…
Read More » - Oct- 2021 -6 OctoberDH Latest News
Denmark and Sweden pause Moderna vaccines for younger population.
Sweden and Denmark announced that they were pausing the use of Covid-19 vaccines from Moderna, for people belonging to younger…
Read More » - Apr- 2021 -1 AprilDH Latest News
Covid-19 vaccine protection last ‘6 months’, effective against variants: Pfizer-BioNTech
The Covid-19 vaccine manufactures Pfizer/BioNTech has claimed that the vaccine will provide 6 month’s immunity. The Pfizer/BioNTech also claimed that…
Read More » - Nov- 2020 -19 NovemberDH Latest News
Virus updates!!! Pfizer says its COVID-19 vaccine ‘94% effective in over 65s’
The corona virus vaccine discovered by Pfizer and BioNTech seems to preserve 94% of adults over 65 years old. Data…
Read More »